CalibreScientific Belgium
ActiveFrom the official registers: KBO 34 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
CalibreScientific Belgium has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €345,784 and a net result of €133,910. Equity has been shrinking by about 25% per year since 2018. If that trend continues, it turns negative around financial year 2026. Its solvency ranks better than 77% of 144 sector peers (NACE 32, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 10-09-1991 Normal situation
- Legal form
- Public limited company
- Registered office
- Gaversesteenweg 55, 9800 Deinze
- Activity
- Manufacture of medical and dental instruments and supplies NACE 32500and 1 other
- Establishment unit
- 2.054.376.658 9800 Deinze, since 30-09-1991
- Financial year end
- 31 December
- Peppol
- Reachable
Board and ownership
Board
- Brian WALLDirector · since 01-01-2025
- Amanda HALFORDDirector · since 15-05-2026
- Usman SHAKEELDirector · since 15-05-2026
- Auditor
- BV MOORE AUDIT
Shareholders
- CALIBRESCIENTIFIC BELGIUM100%annual accounts 2023
- CALIBRE SCIENTIFIC INTERNATIONAL HOLDINGSconsolidatesannual accounts 2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
Annual accounts 2025
- Gross margin
- €297,466
- ▲ 35.3%
- Turnover
- ≈ €700,000
- estimated
- Profit
- €133,910
- ▲ 119%
- Equity
- €345,784
- ▲ 63.2%
- Total assets
- €466,639
- ▲ 47.7%
- Staff
- 2.5 FTE
- ▲ 38.9%
2025 accounts filed 1 day before the deadline
Filed on 30-07-2026at the National Bank
Score breakdownraises risk1 change of registered office in 24 monthslowers riskLiquidity: current ratio 3.85, cash €136,826Founded in 1991Equity €345,784 (74.1% of total assets)Show the evidence
Checked score
Score 2025
96
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 84% of micro companies in other manufacturing (NACE 32)
Financial strength · tick: 2024
Strong
Solvency
99+7
equity 74.1% of total assets
Liquidity
77+9
short-term debt 25.9% · cash 29.3%
Profitability
100+7
return on assets 28.7%
Bankruptcy probability within 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.1%
12-2024: 0.1%● unchanged vs 11-2024
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025lowest value
07-2025: 0.1%● unchanged vs 06-2025
08-2025: 0.2%▲ +0.1 percentage points vs 07-2025
09-2025: 0.7%▲ +0.5 percentage points vs 08-2025highest value
10-2025: 0.2%▼ -0.5 percentage points vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.3%▲ +0.1 percentage points vs 05-2026
07-2026: 0.3%● unchanged vs 06-2026
08-2026: 0.1%▼ -0.2 percentage points vs 07-2026
09-2026: 0.1%● unchanged vs 08-2026
10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.85 (2.99 in 2024), above the usual 1.5. Short-term debt is 25.9% and cash 29.3% of total assets. 25.9% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro). It does better than 79% of them on solvency, 77% on liquidity, 93% on profitability and 89% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €345,784
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
1 day early
2024
56 days late
2023
20 days early
2022
3 days early
2021
18 days late
2020
30 days late
2019
40 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 17 days after the deadline. In the sector (NACE 32), the median for financial year 2024 was 2 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
Key points
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 30-07-2026
- Annual accounts 2024filed on 25-09-2025
- Annual accounts 2023filed on 11-07-2024
- Annual accounts 2022filed on 28-07-2023
Acts in the Belgian Official Gazette
- Resignations & appointmentsact of 01-07-2026
- Resignations & appointmentsact of 16-10-2025
- Registered office · Resignations & appointmentsact of 22-08-2025
- Amendment of the articles · Nameact of 04-10-2024
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about CalibreScientific Belgium
- What is the company number of CalibreScientific Belgium?
- The company number of CalibreScientific Belgium is 0445.025.508. The VAT number is the same number with BE in front: BE 0445.025.508.
- Where is CalibreScientific Belgium based?
- The registered office is at Gaversesteenweg 55, 9800 Deinze.Company details
- What does CalibreScientific Belgium do?
- According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
- What is the legal form of CalibreScientific Belgium?
- The legal form of CalibreScientific Belgium is Public limited company (NV).
- When was CalibreScientific Belgium founded?
- CalibreScientific Belgium was founded on 10-09-1991.
- Is CalibreScientific Belgium still active?
- Yes, CalibreScientific Belgium is an active enterprise in the KBO register.
- How many employees does CalibreScientific Belgium have?
- CalibreScientific Belgium had an average of 2.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of CalibreScientific Belgium?
- The turnover in financial year 2025 is ≈ €700,000. This figure is estimated from the gross margin of €297,466 and 2,285 comparable companies of the same size. It probably lies between €420,000 and €1.2m. It is a rough estimate.
- Is CalibreScientific Belgium profitable?
- In financial year 2025, CalibreScientific Belgium made a profit of €133,910.
- Where can I find the annual accounts of CalibreScientific Belgium?
- CalibreScientific Belgium filed 34 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of CalibreScientific Belgium due?
- CalibreScientific Belgium must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Companies linked to CalibreScientific Belgium
Comparable companies
These companies have the same main activity as CalibreScientific Belgium: manufacture of medical and dental instruments and supplies (NACE 32500). They are comparable in size and age: total assets between €414,000 and €708,000, founded between 1983 and 2005.
| Company | Total assets | Gross margin |
|---|---|---|
| CalibreScientific Belgium Deinze | €466,639 | €297,466 |
| MEDIWELLNESS Mons | €644,698 | €267,533 |
| LEXEL Asse | €414,136 | €243,825 |
| VAN HIMBEECK Antwerpen | €707,599 | €327,712 |
| EYE TO EYE OPTIEK SERVICE Maasmechelen | €552,703 | €323,816 |
| Kronos Dental Overijse | €570,044 | €228,178 |
| OPTIEK PUNIE Diest | €523,805 | €367,270 |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.